THOMAS PIEBER / PROFILE

Physician and scientist.
With perspective.

Prof. Thomas Pieber – clinical experience, scientific curiosity and a commitment to advancing medical knowledge.

Clinical experience as a starting point

Thomas Pieber is a specialist in internal medicine with a focus on endocrinology and metabolism. He heads the Division of Endocrinology and Diabetology at the Medical University of Graz. Diabetes and the advancement of its treatment are central themes in his work.

Medicine, research and responsibility

His career includes international specialist training, academic research and medical leadership of a university hospital. At Elyte Diagnostics, he combines a research idea he originated with his involvement as an investor.

Selected career milestones

  1. 1980–1987

    Medical studies

    University of Graz

  2. 1987–1993

    Specialist training in internal medicine

    Düsseldorf, Dallas and Graz

  3. 1995

    Habilitation

    Internal medicine

  4. 2004–2008

    Medical Director

    University Hospital Graz

  5. 2008

    Appointment as Professor of Internal Medicine

    Medical University of Graz

Selected honours

  • Stefan Schuy Prize, ÖGBMT · 1999
  • Research Prize, Medical University of Graz · 2004
  • University Prize, Federation of Austrian Industries · 2005
  • International Somogyi Award · 2010

CBMED / RESEARCH INTO PRACTICE

Research that
creates connections.

CEO at CBmed, together with Robert Lobnig

Biomarker researchPrecision medicineResearch & industry

CBmed connects clinical and biomedical research with patient-focused application. As CEO, Thomas Pieber contributes his experience in an environment where academic institutions, healthcare providers and industry partners work together.

Translational biomarker research and precision medicine are central themes at CBmed. Biomarkers are measurable biological characteristics that can, for example, help characterise diseases or investigate treatments.

Discover CBmed

PROGRESS STARTS WITH A CONVERSATION.

Let’s explore
what comes next.

Interested in Elyte Diagnostics as an investor, or in discussing the scientific work? Thomas Pieber welcomes a personal conversation.

Request an investor conversation More ways to get in touch